维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="ZURRIDA S"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Conseqences of sentinel node in clinical decision making in breast cancer and prospects for future studies显示文摘	Veronesi U Zurrida S Galimberti V	1998	Eur J Surg Oncol1998，24，：	1
2	Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies 显示文摘	Veronesi U Zurrida S Galimberti V	1998	Eur J Surg Oncol1998，24，1：	1
3	Prognostic significance of number and level of axillary node metastasis in breast cancer显示文摘	Veronesi U Galimberti V Zurrida S	1993	Breast1993，2，：	1
4	Which therapy for unexpected phyllodes tumour of the breast显示文摘	Zurrida S Barrtoli C Galimberti V	1992	Eur J Cancer1992，28，23：	1
5	Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01 ) :a phase 3 randomised controlled trial 显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oneol2013，14，：	1
6	High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy显示文摘	Zurrida S Bagnardi V Curigliano G	2013	Eur J Cancer2013，49，15：	1
7	Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01):a phase 3 randomised controlled trial显示文摘	Galimbei V Cole BF Zurrida S	2013	Lancet Oncol2013，14，4：	1
8	Which therapy for unexpected phyllodes tumor of the breast?显示文摘	ZURRIDA S BARTOLI C GALIMBERTI V	1992	Eur J Cancer1992，28，23：	1
9	The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life显示文摘	Luini A Gatti G Zurrida S	2005	Breast Cancer Research and Treatment2005，89，1：	1
10	Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01):a phase 3 randomised controlled trial显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oncol2013，14，4：	1
11	Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01):a phase 3 randomised controlled trial显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oncol2013，14，4：	1
12	Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases ( IBCSG 23-01 ) : a phase 3 randomised controlled trial显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oncol2013，，4：	1
13	Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution 显示文摘	VIALE G ZURRIDA S MAIORANO E	2005	Cancer2005，103，3：	1
14	Sentinel lymph node biopsy in male patients with early breast cancer 显示文摘	Gentilini O Chagas E Zurrida S el al	2007	Oncologisl2007，12，5：	1
15	Axillary dissection versus no axillary dissection in patients with sentinel-nodemicrometastases (IBCSG 23-01 ): a phase 3 randomised controlled trial 显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oneo12013，14，4：	1
16	Axillary dissection versus axillary dissection in patients with sentinel-node micrometastases ( IBCSG 23-01 ) : a phase 3 randomised controlled trial显示文摘	Galimberti V Cole BF Zurrida S	2013	Lancet Oncol2013，14，：	1
17	Breast conservation: current results and future perspectives at the European Institute of Oncology 显示文摘	Vemnesi U Zurrida S	2007	lnt J Cancer2007，120，7：	1
18	Predicting the status of axillary sentinel lymph nodes in 435 1 patients with invasive breast carcinoma treated in a single institution显示文摘	Viale G Zurrida S Maiorano E	2005	Cancer2005，103，15：	1
19	Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer显示文摘	Veronesi U Galimberti V Zurrida S	2001	Eur J Cancer2001，37，4：	1
20	Rethinking TNM:a breast cancer classification to guide to treatment and facilitate research显示文摘	Veronesi U Zurrida S Viale G	2009	Breast J2009，15，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示